Pharmacy and Medicines Regulatory Authority (PMRA) Director General Mr. Mphatso Kawaye, was on Thursday 15 February 2024 among key speakers at the Second Hybrid Webinar on “India-Malawi Pharmaceutical Cooperation and Regulatory Developments” organized by the Indian High Commission in Malawi in collaboration with Pharmaceuticals Export Promotion Council of India (PHARMEXCIL) in Lilongwe.

The DG made a presentation on Registration Procedures in the Pharmaceutical Sector in Malawi.

Other speakers included Indian High Commissioner to Malawi His Excellency Shri S. Gopalakrishnan, PHARMEXCIL Director General Mr. Ravi Uday Bhaskar, Director of Technical Services at Ministry of Health Mr. Godfrey Kadewere, and Central Medical Stores Director of Procurement Mr Charles Kombeni. 

India is the largest supplier of Malawi’s imported pharma products. 

India is the largest global supplier of generic drugs accounting for 20% of its global exports. It is also the leading vaccine manufacturer globally with a market share of 60%.

Major segments of the Indian Pharmaceutical Industry include generic drugs, OTC medicines, bulk drugs, vaccines, contract research & manufacturing, biosimilars and biologics. India manufactures about 60,000 different generic brands across 60 therapeutic categories and ranks 3rd globally in manufacturing generic drugs.

The objective of the Webinar was to facilitate and promote more pharma trade between India and Malawi. The webinar was followed by Business-to-Business (B2B) meetings. Over 100 companies from both India and Malawi participated at the second Hybrid Buyer-Seller Meet on pharma sector. The first Buyer-Seller Meet was organised in February 2022.